Trial intelligence / Profile preview

Synvisc for Thumb Osteoarthritis

NCT00398866Phase 3Completed

Sponsor
Hospital for Special Surgery
Start
Aug 2006
Primary completion
Mar 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sodium hyaluronate in Osteoarthritis of the thumb (OA) (3 arms), sponsored by Hospital for Special Surgery. Primary endpoint: Pain Visual Analogue Scale at 26 Weeks. Started Aug 2006; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

Osteoarthritis of the thumb (OA)

Beyond the preview

Go deeper on NCT00398866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00398866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call